Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 3/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14794763 | 1.00 | PRCP (0.47) | PRCPTLR2DPP7ALDH1A1ATM | |
| SCHEMBL23485244 | 0.98 | PRCP (0.46) | PRCPTLR2DPP7ALDH1A1ATM | |
| SCHEMBL18903201 | 0.98 | PRCP (0.46) | PRCPTLR2DPP7ALDH1A1ATM | |
| SCHEMBL7293853 | 0.95 | PRCP (0.49) | PRCPTLR2DPP7 | |
| SCHEMBL8257937 | 0.95 | PRCP (0.51) | PRCPTLR2DPP7ALDH1A1ATM | |
| SCHEMBL2638667 | 0.95 | PRCP (0.51) | PRCPTLR2DPP7ALDH1A1ATM | |
| SCHEMBL2713588 | 0.95 | PRCP (0.51) | PRCPTLR2DPP7ALDH1A1ATM | |
| Hydrochloric Acid SCHEMBL8661704 | 0.94 | TLR2 (0.48) | PRCPTLR2DPP7 | |
| SCHEMBL7296427 | 0.94 | PRCP (0.51) | PRCPTLR2DPP7TSHR | |
| Hydrochloric Acid SCHEMBL7366846 | 0.94 | PRCP (0.50) | PRCPTLR2DPP7ALDH1A1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | SHISEIDO COMPANY, LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| CN-101039649-A | Anti-graying preparation | SHISEIDO CO LTD (JP) | 2007-09-19 | — | — | CN | disclosed |
| EP-1806121-A1 | ANTI-GRAYING PREPARATION | Shiseido Company, Limited (JP) | 2007-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | HCAR1, HCAR3, DDC | PRCP 2595/4885TLR2 4496/4885DPP7 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.